Established in 2010, the company is a technology-based enterprise specializing in the research and development, production, sales and service of in vitro rapid diagnostic reagents. The company takes monoclonal antibody technology, molecular immunology technology, nanotechnology and microelectronics technology as its platform, accelerating the research and development of products and constantly launching rapid, sensitive, specific and accurate in vitro diagnostic series products. All product performances and indicators meet industry standards. The company attaches great importance to independent research and development, adhering to the business philosophy of "quality, reputation, service and sincerity" and the quality policy of "perfect quality, sincere service, standardized management and innovation".